PL370541A1 - Live attenuated strains of prrs virus - Google Patents

Live attenuated strains of prrs virus

Info

Publication number
PL370541A1
PL370541A1 PL02370541A PL37054102A PL370541A1 PL 370541 A1 PL370541 A1 PL 370541A1 PL 02370541 A PL02370541 A PL 02370541A PL 37054102 A PL37054102 A PL 37054102A PL 370541 A1 PL370541 A1 PL 370541A1
Authority
PL
Poland
Prior art keywords
live attenuated
prrs virus
attenuated strains
strains
prrs
Prior art date
Application number
PL02370541A
Other languages
Polish (pl)
Inventor
Knut Elbers
Stefan Pesch
Bettina Schuetz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of PL370541A1 publication Critical patent/PL370541A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10061Methods of inactivation or attenuation
    • C12N2770/10062Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL02370541A 2001-03-09 2002-03-07 Live attenuated strains of prrs virus PL370541A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27460301P 2001-03-09 2001-03-09

Publications (1)

Publication Number Publication Date
PL370541A1 true PL370541A1 (en) 2005-05-30

Family

ID=23048885

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370541A PL370541A1 (en) 2001-03-09 2002-03-07 Live attenuated strains of prrs virus

Country Status (12)

Country Link
EP (1) EP1421184A2 (en)
JP (1) JP2004534522A (en)
KR (1) KR20030082960A (en)
BR (1) BR0207988A (en)
CA (1) CA2439254A1 (en)
CZ (1) CZ20032743A3 (en)
HU (1) HUP0303431A2 (en)
MX (1) MXPA03007751A (en)
PL (1) PL370541A1 (en)
RU (1) RU2003129068A (en)
SK (1) SK11282003A3 (en)
WO (1) WO2002072802A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438969A1 (en) * 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine
KR20050040172A (en) * 2003-10-27 2005-05-03 주식회사 중앙백신연구소 Method of porcine reproductive and respiratory syndrome inactivated oil vaccine
KR101152012B1 (en) * 2004-11-19 2012-07-04 인터벳 인터내셔널 비.브이. Porcine reproductive and respiratory syndrome virus strains and compositions
KR100996105B1 (en) * 2005-02-25 2010-11-22 화이자 프로덕츠 인크. N Protein Mutants of Porcine Reproductive and Respiratory Syndrome Virus
US8709730B2 (en) 2007-04-05 2014-04-29 Icahn School Of Medicine At Mount Sinai Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
CN101454442A (en) * 2007-06-15 2009-06-10 普泰克国际有限公司 Construction of chimera PRRSV, compositions and vaccine preparations
EA038012B1 (en) * 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Composition of novel prrsv strain or proteins thereof, product, use thereof, prrsv virus, isolated na and recombinant expression vector for producing the virus
KR101420850B1 (en) * 2011-05-30 2014-08-13 건국대학교 산학협력단 A novel virus like particle of Porcine reproductive and respiratory syndrome virus and vaccine thereof
KR101281361B1 (en) * 2011-07-18 2013-07-02 서울대학교산학협력단 Vaccine composition for North American Porcine reproductive and respiratory syndrome virus and mixed vaccine comprising thereof
KR101245029B1 (en) * 2012-01-18 2013-03-18 서울대학교산학협력단 Vaccine composition for Korean Porcine reproductive and respiratory syndrome virus
JP6386999B2 (en) * 2012-05-17 2018-09-05 ゾエティス・エルエルシー Effective vaccination before weaning for porcine reproductive and respiratory syndrome (PRRS) virus
CN103290142B (en) * 2013-03-29 2015-03-11 云南农业大学 A fluorescent quantitative RT-PCR method for detection of a porcine reproductive and respiratory syndrome (PRRS) attenuated vaccine virus content
KR101624485B1 (en) 2014-08-13 2016-05-26 전북대학교산학협력단 Porcine reproductive and respiratory syndrome virus mutant strain and vaccine composition for preventing or treating porcine reproductive and respiratory syndrome comprising the same
CN104694561B (en) * 2015-02-10 2018-02-23 中国农业科学院上海兽医研究所 Express construction method and the application of the PRRSV recombinant plasmids of sea pansy or firefly luciferase gene
MX2021015938A (en) * 2019-08-29 2022-04-26 Elanco Us Inc Porcine reproductive and respiratory syndrome vaccine virus.
WO2021154055A1 (en) * 2020-01-29 2021-08-05 주식회사 바이오포아 Mutant strain of european porcine reproductive and respiratory syndrome virus and vaccine composition comprising same
KR102276341B1 (en) * 2020-01-29 2021-07-12 주식회사 바이오포아 Method for producing European porcine reproductive and respiratory syndrome virus and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218431B (en) * 1991-06-06 2000-08-28 Stichting Centraal Diergeneeskundig Instituut Lelystad-virus the causative agent of the mystery swine disease, virus derived polypeptides, antigenes and nucleic acids and vaccine compositions to prevent mystery swine disease
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
WO2000053787A1 (en) * 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
UA73915C2 (en) * 1997-05-06 2005-10-17 Стіхтінг Дінст Ландбаувкюндіг Ондерзук Antigenic sites of prrsv defining sequences of proteins of ppcc virus being suitable for use in vaccines or in diagnostics
WO1998055626A2 (en) * 1997-06-05 1998-12-10 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
WO2002095040A1 (en) * 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
CN1406277A (en) * 2000-01-26 2003-03-26 贝林格尔·英格海姆维特梅迪卡有限公司 Recombinant attenuation of PRRSV
EP1156111A1 (en) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
JP2003533989A (en) * 2000-05-24 2003-11-18 メリアル Swine Reproductive and Respiratory Syndrome Virus (PRRSV) Recombinant Poxvirus Vaccine

Also Published As

Publication number Publication date
WO2002072802A2 (en) 2002-09-19
HUP0303431A2 (en) 2004-01-28
MXPA03007751A (en) 2004-11-12
RU2003129068A (en) 2005-04-10
EP1421184A2 (en) 2004-05-26
WO2002072802A3 (en) 2004-03-11
CA2439254A1 (en) 2002-09-19
BR0207988A (en) 2004-10-26
KR20030082960A (en) 2003-10-23
SK11282003A3 (en) 2004-02-03
JP2004534522A (en) 2004-11-18
CZ20032743A3 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
PL370541A1 (en) Live attenuated strains of prrs virus
AU2002229390A1 (en) Attenuated live vaccine
HUP0301413A3 (en) Vaccine compositions
HK1062891A1 (en) Vaccine composition
IL161070A0 (en) Compositions for the treatment of infectious diseases
GB0130215D0 (en) Vaccine
HUP0302636A3 (en) Split enveloped virus preparation
EP1435788A4 (en) Lysin-deficient bacteriophages having reduced immunogenicity
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) Vaccine
IL153879A0 (en) Modified virus
GB0121171D0 (en) Vaccine
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
HUP0201059A2 (en) Vacuum sewer system
GB0227114D0 (en) Preparation of triethyl phostate
ZA200401211B (en) Antigenic compositions
AU2001278337A1 (en) Respiratory syncytial virus vaccine
GB0001475D0 (en) Virus strains
EP1447083A4 (en) Preventives/remedies for viral infection
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
GB0023445D0 (en) Attenuated virus vaccine
GB0113703D0 (en) Attenuated vaccine
AU2002304792A1 (en) Bacteriophage preparation
GB0100430D0 (en) Virus strains
GB0100288D0 (en) Virus strains

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)